This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1r2g
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /> <applet load="1r2g" size="450" color="white" frame="true" align="right" spinBox="true" caption="1r2g, resolution 2.70Å" /> '''Human Bcl-XL contai...)
Next diff →
Revision as of 16:52, 12 November 2007
|
Human Bcl-XL containing a Phe to Trp mutation at position 97
Overview
Cells expressing high levels of the BCL-X(L) anti-apoptotic protein are, preferentially killed by the mitochondrial inhibitor antimycin A (AA)., Computational modeling predicts a binding site for AA in the extended, hydrophobic groove on BCL-X(L), previously identified as an interface for, dimerization to BAX and related proapoptotic proteins. Here, we identify, BCL-X(L) hydrophobic groove mutants with normal cellular anti-apoptotic, function but suppressed sensitivity to AA. The LD(50) of AA for cells, expressing BCL-X(L) mutants directly correlates with the measured in vitro, dissociation constants for AA binding. These results indicate that, BCL-X(L) is a principal target mediating AA cytotoxicity.
About this Structure
1R2G is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Bcl-XL mutations suppress cellular sensitivity to antimycin A., Manion MK, O'Neill JW, Giedt CD, Kim KM, Zhang KY, Hockenbery DM, J Biol Chem. 2004 Jan 16;279(3):2159-65. Epub 2003 Oct 8. PMID:14534311
Page seeded by OCA on Mon Nov 12 18:59:00 2007
